Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Explore value comparisons for travel points redemptions to make informed choices. Get the most out of your rewards.
22,464 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Caterpillar—a 100-year-old icon in heavy equipment—is redefining its path by embracing AI-enabled infrastructure, dat...
AppLovin reported its best quarter in history, with record revenue and an 84% EBITDA margin, but the stock declined s...
Kratos Defense stock just surged after two new contract wins. This article breaks down what happened, why it matters,...
The SPDR S&P Semiconductor ETF jumps roughly 12% amid resilient AI-related demand, yet Intel remains a weakness in an...
New-home sales in December 2025 rose versus a year ago, but prices fell as concessions increased. The release was del...
If you’ve got $1,000 to invest, you don’t need to chase the hottest hype. Here are three durable stocks that recently...
HUD opens a formal review of HECM reforms as proprietary reverse mortgage options expand. Industry leaders weigh in o...
Crypto.com moves closer to a regulated crypto banking model after receiving conditional approval for a national bank ...
Medicare’s 2026 changes could quietly shrink retirees’ monthly checks as higher premiums and income-based surcharges ...
A public figure’s family offers a million-dollar incentive to help locate a missing loved one. This article breaks do...
Looking for cash flow that lasts through retirement without chasing risky yields? Meet two resilient dividend stalwar...